skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

25 Total results for product and free and sample content found

Pink Sheet

Drug Pricing Legislation Appears Nowhere In Sight Following Senate Hearing

By Michael Cipriano 18 Oct 2017

Senators and witnesses rehashed years-old arguments and found little common ground

Topic Reimbursement


Shire Vs Allergan Brings Exclusive Contracts Out Of The Shadows

By Jessica Merrill 04 Oct 2017

Shire filed a lawsuit against Allergan, claiming that Allergan's exclusive contracting tactics for Restasis under Medicare Part D have blocked Xiidra from the market.

Topic Reimbursement

Scrip, In Vivo, Pink Sheet, Medtech Insight

What actually keeps biopharma execs up at night?

07 Sep 2017

What actually keeps biopharma execs up at night? Take our quiz to find out. 

Topic Deal trends Diseases Drug development landscape FDA Medtech Personalized Medicine Parkinsons disease Reimbursement

Pink Sheet

Novartis Begins CAR-T Payment Experiments With Outcomes-Based Contract With CMS

By Cathy Kelly 01 Sep 2017

The Centers for Medicare and Medicaid Services will only pay for Kymriah if patients respond after one month.

Topic Reimbursement

Pink Sheet

Biogen Ventures Into Value-Based Contracts In Multiple Sclerosis

By Cathy Kelly 10 Aug 2017

Four contracts test approaches tying reimbursement to relapse rates and discontinuation of treatment.

Topic Reimbursement

Datamonitor Healthcare

Reimbursement Challenges in the US and Europe

By Tijana Ignjatovik 09 Jun 2017

Informa's Japanese office, a British company that operates Pharma Intelligence, held a special free seminar in Tokyo on May 17, 2017.

Topic Reimbursement

Datamonitor Healthcare

Inside the payer perspective market

08 Jun 2017

Market Access & Reimbursement: Inside the Payer Perspective on Multiple Myeloma

Topic Reimbursement

Pink Sheet

Abuse-Deterrent Opioids: ICER Value Analysis Could Reinforce Coverage Restrictions

By Cathy Kelly 12 May 2017

Draft report concludes that added cost of abuse-deterrent opioids is not outweighed by reductions to health care system costs resulting from their use.

Topic Reimbursement


BioMarin Expects 30% Markdown For Orphan Pediatric Drug Brineura

By Emily Hayes 02 May 2017

Fast US approval of ultra-rare pediatric disease drug Brineura (cerliponase alfa), with an annual list price of $702,000, is a victory for the company, but approval for restricted pediatric population compared to Europe raised questions.

Topic Rare Disease Reimbursement

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907
  • Japan            : +81 3-6273-4257

Or email us your inquiry, so we can provide you the best possible customer service:

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: